CN103097356B - 13-环己基-3-甲氧基-6-[甲基-(2-{2-[甲基-(氨磺酰基)-氨基]-乙氧基}-乙基)-氨基甲酰基]-7H-吲哚并-[2,1-a]-[2]-苯并氮杂*-10-羧酸的制备 - Google Patents
13-环己基-3-甲氧基-6-[甲基-(2-{2-[甲基-(氨磺酰基)-氨基]-乙氧基}-乙基)-氨基甲酰基]-7H-吲哚并-[2,1-a]-[2]-苯并氮杂*-10-羧酸的制备 Download PDFInfo
- Publication number
- CN103097356B CN103097356B CN201180030949.0A CN201180030949A CN103097356B CN 103097356 B CN103097356 B CN 103097356B CN 201180030949 A CN201180030949 A CN 201180030949A CN 103097356 B CN103097356 B CN 103097356B
- Authority
- CN
- China
- Prior art keywords
- acid
- methyl
- ethyl
- compound
- sulfamyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10167221 | 2010-06-24 | ||
EP10167221.0 | 2010-06-24 | ||
PCT/EP2011/060606 WO2011161232A1 (en) | 2010-06-24 | 2011-06-24 | PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103097356A CN103097356A (zh) | 2013-05-08 |
CN103097356B true CN103097356B (zh) | 2016-01-13 |
Family
ID=43216626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180030949.0A Expired - Fee Related CN103097356B (zh) | 2010-06-24 | 2011-06-24 | 13-环己基-3-甲氧基-6-[甲基-(2-{2-[甲基-(氨磺酰基)-氨基]-乙氧基}-乙基)-氨基甲酰基]-7H-吲哚并-[2,1-a]-[2]-苯并氮杂*-10-羧酸的制备 |
Country Status (11)
Country | Link |
---|---|
US (2) | US9127010B2 (zh) |
EP (1) | EP2585438B1 (zh) |
JP (1) | JP5870098B2 (zh) |
CN (1) | CN103097356B (zh) |
AU (1) | AU2011268922B2 (zh) |
BR (1) | BR112012032889A2 (zh) |
CA (1) | CA2801517C (zh) |
IL (1) | IL223427A (zh) |
MX (1) | MX2012015198A (zh) |
RU (1) | RU2559886C2 (zh) |
WO (1) | WO2011161232A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI454476B (zh) | 2008-07-08 | 2014-10-01 | Tibotec Pharm Ltd | 用作c型肝炎病毒抑制劑之巨環吲哚衍生物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
CN1116288C (zh) | 1996-04-23 | 2003-07-30 | 沃泰克斯药物股份有限公司 | 用作肌苷-5'-一磷酸脱氢酶抑制剂的脲衍生物 |
DE69816280T2 (de) | 1997-03-14 | 2004-05-27 | Vertex Pharmaceuticals Inc., Cambridge | Inhibitoren des impdh-enzyms |
IL145475A0 (en) | 1999-03-19 | 2002-06-30 | Vertex Pharma | Compounds that inhibit impdh enzyme and pharmaceutical compositions containing the same |
KR100891240B1 (ko) | 2000-08-30 | 2009-04-01 | 파나소닉 주식회사 | 플라즈마 디스플레이 표시장치 및 그 제조방법 |
US7153848B2 (en) | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
EP1937272A2 (en) | 2005-09-02 | 2008-07-02 | Tibotec Pharmaceuticals Ltd. | Benzodiazepines as hcv inhibitors |
US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
GB0522881D0 (en) | 2005-11-10 | 2005-12-21 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
WO2007092000A1 (en) | 2006-02-06 | 2007-08-16 | Bristol-Myers Squibb Company | Inhibitors of hcv replication |
US7456166B2 (en) | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521443B2 (en) | 2006-05-17 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521441B2 (en) | 2006-05-22 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
WO2007140200A2 (en) | 2006-05-25 | 2007-12-06 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
AU2007335962B2 (en) | 2006-12-20 | 2012-09-06 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Antiviral indoles |
EP2178885A1 (en) | 2007-07-17 | 2010-04-28 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Macrocyclic indole derivatives for the treatment of hepatitis c infections |
TWI454476B (zh) | 2008-07-08 | 2014-10-01 | Tibotec Pharm Ltd | 用作c型肝炎病毒抑制劑之巨環吲哚衍生物 |
-
2011
- 2011-06-24 AU AU2011268922A patent/AU2011268922B2/en not_active Ceased
- 2011-06-24 BR BR112012032889A patent/BR112012032889A2/pt not_active IP Right Cessation
- 2011-06-24 RU RU2013103004/04A patent/RU2559886C2/ru not_active IP Right Cessation
- 2011-06-24 CA CA2801517A patent/CA2801517C/en not_active Expired - Fee Related
- 2011-06-24 JP JP2013515907A patent/JP5870098B2/ja not_active Expired - Fee Related
- 2011-06-24 EP EP11727184.1A patent/EP2585438B1/en not_active Not-in-force
- 2011-06-24 WO PCT/EP2011/060606 patent/WO2011161232A1/en active Application Filing
- 2011-06-24 US US13/805,607 patent/US9127010B2/en not_active Expired - Fee Related
- 2011-06-24 MX MX2012015198A patent/MX2012015198A/es active IP Right Grant
- 2011-06-24 CN CN201180030949.0A patent/CN103097356B/zh not_active Expired - Fee Related
-
2012
- 2012-12-04 IL IL223427A patent/IL223427A/en active IP Right Grant
-
2015
- 2015-07-28 US US14/810,783 patent/US20150329482A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN103097356A (zh) | 2013-05-08 |
BR112012032889A2 (pt) | 2015-09-15 |
AU2011268922A1 (en) | 2013-01-10 |
RU2559886C2 (ru) | 2015-08-20 |
RU2013103004A (ru) | 2014-07-27 |
AU2011268922B2 (en) | 2014-06-12 |
US9127010B2 (en) | 2015-09-08 |
CA2801517C (en) | 2017-12-12 |
WO2011161232A1 (en) | 2011-12-29 |
EP2585438B1 (en) | 2014-08-20 |
US20150329482A1 (en) | 2015-11-19 |
JP2013530976A (ja) | 2013-08-01 |
MX2012015198A (es) | 2013-02-11 |
JP5870098B2 (ja) | 2016-02-24 |
CA2801517A1 (en) | 2011-12-29 |
US20130102777A1 (en) | 2013-04-25 |
IL223427A (en) | 2015-04-30 |
EP2585438A1 (en) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6609065B2 (ja) | 1−(5−(2,4−ジフルオロフェニル)−1−((3−フルオロフェニル)スルホニル)−4−メトキシ−1h−ピロール−3−イル)−n−メチルメタンアミンの新規な酸付加塩 | |
CN102131792B (zh) | 用于制备凋亡启动子abt-263的方法 | |
Lutker et al. | Polymorphs and hydrates of acyclovir | |
US7956048B2 (en) | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | |
CN107176953A (zh) | 取代的苯甲醛化合物及其用于增加组织氧合的方法 | |
EP3190102B1 (en) | CRYSTAL OF (S)-1-(2-HYDROXYETHYL)-4-METHYL-N- [4-(METHYLSULFONYL)PHENYL]-5-[2-(TRIFLUOROMETHYL)& xA;PHENYL]- 1H-PYRROLE-3-CARBOXAMIDE | |
WO2007043621A1 (ja) | プラジエノライド b及びプラジエノライド dの全合成方法 | |
CN108329303A (zh) | 制备手性化合物的方法 | |
JP2016028085A (ja) | ダルナビルの多形及びその製造方法 | |
KR20180128907A (ko) | 면역조절제로서 작용하는 트리시클릭 화합물 (tricyclic compound serving as immunomodulator) | |
CN106661074A (zh) | 磷酰胺的合成 | |
KR20150140871A (ko) | 프라수그렐 염의 결정형 | |
CN105992761A (zh) | 具有血小板生成素受体激动作用的光学活性的化合物及其中间体的制备方法 | |
CN103097356B (zh) | 13-环己基-3-甲氧基-6-[甲基-(2-{2-[甲基-(氨磺酰基)-氨基]-乙氧基}-乙基)-氨基甲酰基]-7H-吲哚并-[2,1-a]-[2]-苯并氮杂*-10-羧酸的制备 | |
Reckeweg et al. | Single-crystal structures and vibrational spectra of Li [SCN] and Li [SCN]· 2H2O | |
Bi et al. | Reversible dynamic isomerism change in the solid state, from Bi 4 I 16 clusters to BiI 4 1D chains in l-cystine based hybrids: templating effect of cations in iodobismuthate network formation | |
Yu et al. | Host–guest inclusion complexes of four partial alkyl-substituted cucurbit [6] urils with some probe guests | |
CN117751112A (zh) | 杂芳-3-哌啶二酮类化合物及其应用 | |
Ni et al. | Crystal structures of host–guest complexes of meta-tricyclohexyl cucurbit [6] uril with small organic molecules | |
Ma et al. | Macrocyclic compounds as chiral solvating agents for phosphinic, phosphonic, and phosphoric acids | |
Mei et al. | Biotin and biotin analogues specifically modify the fluorescence decay of avidin | |
JP2023511188A (ja) | セファロスポリン系抗菌化合物及びその医薬的応用 | |
KR20120053027A (ko) | 페소테로딘 푸마레이트 및 페소테로딘 염기의 결정형 | |
TW202110852A (zh) | 用於產生二氮雜螺內醯胺化合物之方法及中間物 | |
CN104105699B (zh) | (1r,4r)-6’-氟-N,N-二甲基-4-苯基-4’,9’-二氢-3’H-螺[环己烷-1,1’-吡喃并[3,4,b]吲哚]-4-胺盐酸盐的固体形式 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: IRELAND JANSSEN R + D COMPANY Free format text: FORMER OWNER: JANSSEN R + D IRELAND Effective date: 20150728 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150728 Address after: The Irish Village Applicant after: Ireland Jansen scientific company Address before: Kirk County, Ireland Applicant before: Tibotec Pharm Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160113 Termination date: 20190624 |